Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives
Open Access
- 5 March 2021
- Vol. 10 (3), 565
- https://doi.org/10.3390/cells10030565
Abstract
Myelin is the lipid-rich structure formed by oligodendrocytes (OLs) that wraps the axons in multilayered sheaths, assuring protection, efficient saltatory signal conduction and metabolic support to neurons. In the last few years, the impact of OL dysfunction and myelin damage has progressively received more attention and is now considered to be a major contributing factor to neurodegeneration in several neurological diseases, including amyotrophic lateral sclerosis (ALS). Upon OL injury, oligodendrocyte precursor cells (OPCs) of adult nervous tissue sustain the generation of new OLs for myelin reconstitution, but this spontaneous regeneration process fails to successfully counteract myelin damage. Of note, the functions of OPCs exceed the formation and repair of myelin, and also involve the trophic support to axons and the capability to exert an immunomodulatory role, which are particularly relevant in the context of neurodegeneration. In this review, we deeply analyze the impact of dysfunctional OLs in ALS pathogenesis. The possible mechanisms underlying OL degeneration, defective OPC maturation, and impairment in energy supply to motor neurons (MNs) have also been examined to provide insights on future therapeutic interventions. On this basis, we discuss the potential therapeutic utility in ALS of several molecules, based on their remyelinating potential or capability to enhance energy metabolism.Keywords
Funding Information
- Fondazione AriSLA (GPR17ALS-1, “Department of excellence” 2018-2022, 2019_BS_006)
This publication has 240 references indexed in Scilit:
- Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosisNature Neuroscience, 2013
- Oligodendroglia metabolically support axons and contribute to neurodegenerationNature, 2012
- Glycolytic oligodendrocytes maintain myelin and long-term axonal integrityNature, 2012
- Proteomic identification of novel targets regulated by the mammalian target of rapamycin pathway during oligodendrocyte differentiationGlia, 2011
- Neuroinflammation modulates distinct regional and temporal clinical responses in ALS miceBrain, Behavior, and Immunity, 2011
- Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutationActa Neuropathologica, 2011
- Oligodendrocytes: biology and pathologyActa Neuropathologica, 2009
- The oligodendrocyte-specific G protein–coupled receptor GPR17 is a cell-intrinsic timer of myelinationNature Neuroscience, 2009
- Oxidative stress disrupts oligodendrocyte maturationJournal of Neuroscience Research, 2009
- Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosisNature Neuroscience, 2008